Working Life: We are part of a global effort to develop gene editing as a therapy for CF

Patrick Harrison PhD, Cystic Fibrosis Gene Editing Group, Department of Physiology, UCC

Patrick Harrison PhD, Cystic Fibrosis Gene Editing Group, Department of Physiology, UCC.  Picture: Tomas Tyner

9am

First up, an online meeting with my research team to discuss gene editing strategies that correct some rare DNA mutations that cause cystic fibrosis (CF). Approximately 5,000 people worldwide have these rare mutations and the new CF drugs launched last year don’t work for them.